Sema4 Stock

sema4.comHealthcareFounded: 2015Funding to Date: $368.26MM

Sema4 is the developer of an AI-driven patient-centered genomic and clinical data insight platform designed to to transform healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology.

Register for Details

For more details on financing and valuation for Sema4, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Sema4.

Register Today

Other companies like Sema4 in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B

News

The firm will use its suite of assays to characterize samples from 5,000 advanced cancer patients from underserved communities and create a representative biobank.
Sema4 beat the consensus Wall Street estimate on the top and bottom lines for Q4 and said it expects between $215 million and $225 million in revenues for 2022.